We describe the framework of a data-fuelled, interdisciplinary team-led learning system. The idea is to build models by using patients from one's own institution whose features are similar to an index patient as regards an outcome of interest. This is done in order to predict the utility of the diagnostic tests and interventions as well as to inform prognosis. The Laboratory of Computational Physiology at the Massachusetts Institute of Technology developed MIMIC-II and maintains it, a public de-identified high-resolution database of patients admitted to Beth Israel Deaconess Medical Center. It hosts teams of clinicians (nurses, doctors, pharmacists) and scientists (database engineers, modelers, epidemiologists) who translate the day-to-day questions during rounds that have no clear answers in the current medical literature into study designs, perform the modeling and analysis. Then, they publish their findings. The studies fall into the following broad categories: identification and interrogation of practice variation, predictive modeling of clinical outcomes within the patient subsets and comparative effectiveness research on diagnostic tests and therapeutic interventions. Clinical databases such as MIMIC-II, where recorded health care transactions -clinical decisions linked with patient outcomesare constantly uploaded. They become the centerpiece of a learning system.
I. INTRODUCTION
Clinical databases provide a unique opportunity to evaluate practice variation, the impact of diagnostic and treatment decisions on patient outcomes. When applied for research purposes, they have potential advantages compared to randomized clinical trials which include lower marginal costs, readily-accessible large and diverse patient study populations, and shorter study execution time periods. Critically ill patients are an ideal population for clinical database investigations as the clinical value of many treatments and interventions they receive is uncertain and high-quality data supporting or discouraging specific practices is relatively sparse.
In practice, each clinician initiates a particular diagnostic test or treatment, informed from their training and Leo A. Celi et al.
experience, and local practice norms (see Fig. 1 ). In a sense each intervention is an "experiment".
In the light of uncertainty with regard to the clinical value of treatments and interventions in the intensive care unit, and the implications that this evidence gap has on clinical outcomes, So, we have developed a collaborative approach (see Fig. 2 ) to a data-fuelled practice by using a high-resolution intensive care unit (ICU) database called MIMIC-II [1] . With support from the National Institutes of Health (NIBIB grant 2R01-001659), the Laboratory of Computational Physiology (LCP) at the Massachusetts Institute of Technology (MIT) developed MIMIC-II and maintains it. It is a public de-identified database of ~40,000 ICU admissions (version 2.6) to Beth Israel Deaconess Medical Center (BIDMC). Our approach hinges on the creation of a learning system that enables aggregation and analysis of the wealth of individual treatment experiments undertaken by clinicians in the ICU. Thereby, it facilitates data-driven practice rather than one that is driven predominantly by an individual clinician preference and the existing ICU culture. The laboratory hosts teams of clinicians (nurses, doctors, pharmacists) and scientists (database engineers, modelers, epidemiologists) who translate day-to-day questions typically asked during medical rounds that often have no clear answers in the current medical literature into study designs and then perform the modeling and the analysis. Then, they publish their findings. The studies fall into the following broad categories: identification and interrogation of practice variation, predictive modeling of clinical outcomes within the patient's subsets and comparative effectiveness research on diagnostic tests and therapeutic interventions. The vision is a data-fuelled, inter-disciplinary team-led learning system that aggregates and analyses day-to-day experimentations as captured in clinical databases, where new knowledge is constantly extracted and propagated for quality improvement, and where practice is driven by outcomes, and less so by individual clinician knowledge base and experience and the local medical culture.
II. METHODS

A. Data Collection
The ICU data in MIMIC-II were collected from 2001 to 2008 at BIDMC in Boston, MA, USA. Adult data were acquired from four ICUs at BIDMC: medical intensive care unit (MICU), surgical intensive care unit (SICU), coronary care unit (CCU), and cardiac surgery recovery unit (CSRU). MIMIC-II also contains data from the neonatal intensive care unit (NICU) of BIDMC, but this paper focuses only on the adult data, which make up the majority of MIMIC-II. Moreover, this study was approved by the Institutional Review Boards of BIDMC and the Massachusetts Institute of Technology.
Two types of data were obtained: clinical data and physiological waveforms. The clinical data were acquired from the CareVue Clinical Information System (models http://jcse.kiise.org M2331A and M1215A; Philips Healthcare, Andover, MA, USA) and the hospital's electronic archives. The data included patient demographics, nursing notes, discharge summaries, continuous intravenous drip medications, laboratory test results, nurse-verified hourly vital signs, etc. Table 1 describes the different clinical data types in MIMIC-II by offering examples to each type. The physiological waveforms were collected from bedside monitors (Component Monitoring System Intellivue MP-70; Philips Healthcare) and included high-resolution (125 Hz) waveforms (e.g., electrocardiograms), derived time series such as heart rate, blood pressures, and oxygen saturation (either once-per-minute or once-per-second), and monitor-generated alarms. Fig. 3 shows an example of highresolution waveforms.
B. Database Organization
After data collection, the clinical data were processed and imported into a relational database that can be queried by using Structured Query Language [2] . Some of the clinical data are in standardized formats (e.g., International Classification of Diseases, Diagnosis Related Group, Current Procedural Terminology, etc.) but the clinical database does not follow a standardized structure as such a standard did not exist, to the best of our knowledge, during the creation of MIMIC-II. The database was organized according to the individual patients at the highest level. A given patient may have had multiple hospital admissions and each hospital admission in turn could have included multiple ICU stays; within the same hospital admission, ICU stays separated by a gap greater than 24 hours were counted separately. Unique subject, hospital admission, and ICU stay IDs were linked to one another to indicate relationships among patients, hospital admissions, and ICU stays.
The physiological waveforms were converted from the proprietary Philips format to an open source format (WFDB) [3] (one of the widely used physiological waveform formats) to be stored separately from the clinical data. As the clinical and physiological data originated from different sources, they had to be matched to each other by the confirmation from a common patient source [4] . Although unique identifiers such as medical record numbers and patient names were utilized for this matching task, a significant portion of the physiological waveforms lacked such an identifier and this resulted in limited matching success. Moreover, waveform data collection spanned a shorter period of time than clinical data collection due to the technical issues. So for many ICU stays waveform data were not collected in the first place.
C. De-identification
In order to comply with the Health Insurance Portability and Accountability Act, MIMIC-II was de-identified by removing the protected health information (PHI). The entire time course of each patient (all hospital admissions and ICU stays) was also time-shifted to a hypothetical period in the future. This de-identification was a straightforward task for structured data fields but this was a chal- Leo A. Celi et al.
lenging task for free-text data such as nursing notes and discharge summaries. Thus, an automated de-identification algorithm was developed. Moreover, it showed better performance than human clinicians in detecting PHI in free-text documents. For more details about this opensource algorithm, please see [5, 6] .
D. Public Access
In order to gain free access to MIMIC-II, any interested researcher just needs to complete a data use agreement and human subjects training. The actual access occurs over the Internet. The clinical data can be accessed either by downloading a flat-file text version or via a live connection through password-protected web service. The physiological waveforms are best accessed by using the WFDB software package. For detailed information regarding obtaining access to MIMIC-II, please refer to the MIMIC-II website: http://physionet.org/mimic2.
E. Using MIMIC-II in Clinical Practice
A program between the engineers at LCP and clinicians at BIDMC was launched in September 2010 to facilitate the use of MIMIC-II in day-to-day clinical practice. The scientists join along with the clinicians on rounds to gain a better understanding of the clinical medicine. They help to identify information gaps that may be addressed by data modeling using MIMIC-II. A question that arises during rounds such as "What is the effect of being on a selective serotonin reuptake inhibitor (antidepressant) has on clinical outcomes of a patient who has sepsis?" triggers an iterative process participated in by both clinicians and engineers. This leads to a study design, the outcomes of interest, a list of candidate predictors, eventual data modeling and an analysis to answer the question. Table 2 tabulates the adult patient statistics in MIMIC-II, stratified with respect to the four critical care units. A total of 26,870 adult hospital admissions and 31,782 adult ICU stays were included in MIMIC-II. MICU patients formed the largest proportion among the 4 care units, while CCU patients made up the smallest cohort. Only 15.7% of all ICU stays were successfully matched to the waveforms. In terms of neonates, 7,547 hospital admissions and 8,087 NICU stays were added to MIMIC-II.
III. RESULTS
Among the adults, the overall median ICU and hospital lengths of stay were 2.1 and 7 days, respectively. CSRU patients were characterized by their high utilization of mechanical ventilation, Swan-Ganz, invasive arterial blood pressure monitoring, and vasoactive medications. Overall, 45.8% and 53.1% of all adult ICU stays utilized mechanical ventilation and invasive arterial blood pressure monitoring, respectively. In-hospital mortality rate was the highest in the MICU (16%) and lowest in the CSRU (3.7%). The overall in-hospital mortality was 11.5%. The ensuing sections describe a few representative projects in progress.
A. Outcome of Critically Ill Patients with Acute Kidney Injury Using the Acute Kidney Injury Network Criteria
Acute kidney injury (AKI) affects 5-7% of all the hospitalized patients. There is a much higher incidence in the critically ill patients. AKI carries considerable morbidity and mortality but it has historically been defined vaguely, with more than 35 denitions of AKI having been used in the literature. This situation is a cause of confusion as well as an ill dened association between acute renal dysfunction and morbidity and mortality. Hence, in 2002 the Acute Dialysis Quality Initiative (ADQI) dened universal criteria for AKI and this was revised in 2005 by the Acute Kidney Injury Network (AKIN). The American Thoracic Society in a recent statement aimed to reduce the occurrence of AKI. It emphasized on the role of urine output (UO) measurements in the early detection of AKI. As of now only a small number of large population studies have been performed and none of them used valid hourly UO measurements in order to detect AKI. We therefore preformed a retrospective cohort study in assessing the influence of AKI, including UO, on the hospital mortality in critically ill patients.
This study [7] utilized adult patients admitted to BIDMC ICUs between 2001 and 2007 in MIMIC-II. We included all the adult patients who had at least 2 creatinine (CR) measurements and who had at least a 6 hours period with 3 bi-hourly UO measurements. Patients who had end stage renal disease were excluded from the cohort. We applied the AKIN criteria by using CR measurements and hourly UO from nursing reports. We classified the patients by their worst combined (UO or CR) AKI stage.
19,677 adult patient records were assessed. After the exclusion of patients who did not meet the inclusion criteria, the cohort included 17,294 patients. Nearly 52.5% of the patients developed AKI during their ICU stay. AKI 1 was the most frequent stage of AKI (36%) followed by AKI 2 (12.5%) and AKI 3 (4%). Hospital mortality rates were higher in all the patients that were found to have AKI (15.5% vs. 3% in patients with no AKI; p < 0.0001). In-hospital mortality rates by stage of AKI were 7.6%, 9.7%, and 24.7% for AKI 1, 2, and 3, respectively, compared to only 3% in patients without AKI (p < 0.0001). After the adjustment of multiple covariates (age, gender, comorbidities, admission non-renal SOFA score) by using multivariate logistic regression, AKI was associated with an increased hospital mortality (odds ratio [OR] 1.3 for AKI 1 and AKI 2, and 2.6 for AKI 3; p < 0.0001, area under the curve [AUC] = 0.79).
Using the same multivariate logistic regression, we found out that in patients who developed AKI, UO alone was a better mortality predictor then CR alone or the 
B. Long Term Outcome of Minor Troponin Elevations in the ICU
Serum troponin assay is an integral part in the diagnosis of an acute myocardial infarction. The term troponin leak refers to a slight elevation and without a clinical diagnosis of an infarction. There are very few studies that look into its significance in the critical care setting as regards long-term outcome. Using the MIMIC-II database, patients with a troponin level >0.01 but <0.5 and without a diagnosis of acute coronary syndrome will be identified. All these patients were admitted in the ICU (MICU, SICU, CCU, and CSRU) from 2001 to 2008 at BIDMC. The purpose of this study is to determine whether or not the troponin level is associated with 1-year survival among these patients. ICU and hospital length-ofstay will also be assessed as secondary outcomes. Cox and logistic regression models will be adjusted for age, Simplified Acute Physiologic Score (SAPS), Sequential Organ Failure Assessment (SOFA), and Elixhauser scores. This analysis will give additional information with regard to clinical application of this indeterminate range of troponin level.
C. Quantifying the Risk of Broad-Spectrum Antibiotics
Current evidence-supported best practice for the management of bacterial sepsis includes the prompt administration of parenteral antimicrobials targeted toward the suspected source of infection. When a diagnosis of a noninfectious etiology of hypoperfusion is made, empiric antimicrobials are no longer indicated. The objective of this study is to quantify the impact of antimicrobial exposure on clinical outcomes. This includes mortality, length of stay, adverse effects of antimicrobials, and acquisition of antimicrobial-resistant organisms. The study population will include patients admitted to the intensive care unit from the emergency department at BIDMC with a diagnosis of sepsis and/or shock, who are started on broad-spectrum antimicrobials on admission, and who have blood cultures obtained on admission that are subsequently negative. A case-control study will be performed in comparing clinical outcomes among patients who receive parenteral antimicrobials for >48 hours after admission (cases) and those receiving parenteral antimicrobials <48 hours after admission (controls).
IV. DISCUSSION
We introduce an approach to decision support by using one's own clinical database as an alternative to built-in expert systems derived from published large, usually multicenter, interventional and observational studies. Clinical trials tend to enroll heterogeneous groups of patients in order to maximize the external validity of their findings. As a result, the recommendations that arise from these studies tend to be general and they are applicable to an average patient. Similarly, predictive models developed by using this approach perform poorly when applied to specific subsets of patients or patients from a different geographic location as the initial cohort [8] .
Using a clinical database, we demonstrated an accurate prediction on the fluid requirement of ICU patients who are receiving vasopressor agents by using the physiological variables during the previous 24 hours in the ICU [9] . Subsequently, we demonstrated improved mortality prediction among ICU patients who developed AKI by building models on this subset of patients [10] .
Clinical databases may also address evidence gaps which are not otherwise filled by prospective randomized controlled trials (RCTs). The breadth of the clinical questions that can be answered with these studies is limited by their high resource demands. Moreover, the quality of data they produce also has challenges. In one study, Ioannidis [11] demonstrated that researchers' findings may frequently be incorrect. Challenges with many clinical studies are extensive. This includes questions that researchers pose like, how studies are designed, which patients are recruited, what measurements are taken, how data are analyzed, how results are presented, and which studies are published. They typically enroll a heterogeneous group of patients in order to maximize the external validity of their findings. However, their findings represent a range of individual outcomes. This may not be applicable to an individual patient. In another study by Ioannidis [12] , he examined 49 highly-cited clinical research studies and found out that 45 articles reported a statistically significant treatment effect, but 14 of 34 articles (41%) which were retested. It was concluded that the original results were incorrect or significantly exaggerated. Systematic reviews also face challenges. While frequently cited as evidence to guide clinical guidelines and healthcare policy, they rarely provide unequivocal conclusions. A 2007 analysis of 1,016 systematic reviews from all 50 Cochrane Collaboration Review Groups found out that 49% of the studies concluded that current evidence "did not support either benefit or harm" [13] . In 96% of the reviews, further research was recommended.
In MIMIC-II, we have successfully created a publicly available database for the intensive care research community. MIMIC-II is a valuable resource, especially for those researchers who do not have easy access to the clinical intensive care environment. Furthermore, research studies based on MIMIC-II can be compared with one another in an objective manner. This will reduce redundancy in research and foster more streamlined advancement in the research community as a whole.
The diversity of data types in MIMIC-II paves way for a variety of research studies. One important type of research that can stem from MIMIC-II is the development and evaluation of automated detection, prediction, and estimation algorithms. The high temporal resolution and multi-parameter nature of MIMIC-II data are suitable for the development of clinically useful and robust algorithms. Moreover, it is easy to simulate a real-life ICU in offline mode. This enables inexpensive evaluation of developed algorithms without the risk of disturbing the clinical staff. Previous MIMIC-II studies in this research category include hypotensive episode prediction [14] and robust heart rate and blood pressure estimation [15] . Additional signal processing studies based on MIMIC-II include false arrhythmia alarm suppression [16] and signal quality estimation for the electrocardiogram [17] .
Another type of research that MIMIC-II can support is the retrospective clinical studies. While prospective clinical studies are expensive to design and perform, retrospective studies are inexpensive, demand substantially less timecommitment, and it also allows flexibility in study design. MIMIC-II offers severity scores such as the SAPS I [18] and SOFA [19] that can be employed in multivariate regression models to adjust for differences in patient conditions. For example, Jia and colleagues [20] investigated on the risk factors for acute respiratory distress syndrome in mechanically ventilated patients, and Lehman and colleagues [21] studied hypotension as a risk factor for AKI.
MIMIC-II users should note that real-life human errors and noise are preserved in MIMIC-II as no artificial cleaning or filtering was applied. Although it presents a challenge, it is also an opportunity for researchers to work with real data and address pragmatic issues.
As MIMIC-II is a single-center database that originates from a tertiary teaching hospital, research results stemming from MIMIC-II may be subject to institutional or regional bias. However, many research questions can be answered independent of the local culture or geographic location (e.g., the focus of the study is physiology).
A successful MIMIC-II study requires a variety of expertise. While clinically-relevant research questions will best come from clinicians, reasonable database and computer skills are necessary to extract data from MIMIC-II. Hence, a multi-disciplinary team of computer scientists, biomedical engineers, biostatisticians, and intensive care clinicians is strongly encouraged in designing and conducting a research study by using MIMIC-II.
There is a long road ahead before our vision of probabilistic modeling at the point-of-care to assist clinicians with contextual questions regarding individual patients becomes a reality. Non-trivial pre-processing and processing issues when mining large high-resolution clinical data-bases abound. Mechanisms to close the information loop should be in place so as to feed the new information back to clinicians. There should be dedicated personnel who consist of data engineers and clinical informaticians to operationalize this learning system. More importantly, impact studies are required to evaluate whether this approach will influence a clinician's behavior and improve patient outcomes.
V. CONCLUSION
We described the framework of a learning system that facilitates the routine use of empirical data as captured by electronic information systems to address areas of uncertainty during day-to-day clinical practice. While evidencebased medicine has overshadowed empirical therapies, we argue that each patient interaction, particularly when recorded with granularity in an easily accessible and computationally convenient electronic form, has the potential to aggregate and analyze daily mini-experiments that occur in areas where standards of care do not exist. Clinical databases such as MIMIC-II can complement the knowledge attained from traditional evidence-based medicine. Moreover, it can provide important insights from routine patient care devoid of the influence of the artificiality that is introduced by research methodologies. As a meta-research tool, clinical databases where recorded health care transactions -clinical decisions linked with patient outcomes -are constantly uploaded, become the centerpiece of a learning system that accelerates both the accrual and dissemination of knowledge.
